Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20th Street South, Faculty Office Tower 820D, Birmingham, AL, 35294, USA.
Rheumatology Unit, University of Verona, Pz Scuro 10, 37135, Verona, Italy.
Curr Osteoporos Rep. 2019 Dec;17(6):521-526. doi: 10.1007/s11914-019-00551-9.
In this review, we present the application of pragmatic clinical trials for evaluating interventions in osteoporosis, and we discuss methodological considerations for designing and conducting a pragmatic clinical trial compared with a classical randomized clinical trial.
Pragmatic clinical trials are a popular study design testing effectiveness of health interventions and are intended to address the limitations associated with traditional explanatory randomized clinical trials testing efficacy of interventions. To date, only few pragmatic clinical trials have been conducted in osteoporosis. Pragmatic clinical trials are conducted under routine clinical practice setting and are intended to inform policy makers and clinical decisions. Osteoporosis is a chronic disease well-suited to this particular study design given the existence of a clear and specific natural endpoint, namely fracture occurrence, and the availability of several treatments to prevent fractures.
在本次综述中,我们介绍了实用临床试验在评估骨质疏松症干预措施中的应用,并讨论了与经典随机临床试验相比,设计和实施实用临床试验的方法学考虑。
实用临床试验是一种流行的研究设计,用于测试健康干预措施的有效性,旨在解决与传统解释性随机临床试验测试干预措施疗效相关的局限性。迄今为止,骨质疏松症中仅进行了少数几项实用临床试验。实用临床试验是在常规临床实践环境中进行的,旨在为决策者和临床决策提供信息。骨质疏松症是一种慢性疾病,非常适合这种特定的研究设计,因为存在明确和具体的自然终点,即骨折发生,并且有几种治疗方法可预防骨折。